Across TCGA pan-cancer cohorts, SDR42E1P5 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of SDR42E1P5’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where SDR42E1P5 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SDR42E1P5 is over-expressed in tumor.
KIRC and THCA are the cancer types where SDR42E1P5 tumor–normal differential expression is most reproducible.